December 2021 FDA Recall Metoprolol Tartrate by Rubicon Research Private Limited (D-0362-2022 - Complaint received of foreign matter (metal) embedded in tablet.)

This Class II drug recall was voluntarily initiated by Rubicon Research Private Limited on December 31, 2021 for the product Metoprolol Tartrate. The FDA reported the reason for recall as complaint received of foreign matter (metal) embedded in tablet.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0362-2022

Reason for Recall
Complaint received of foreign matter (metal) embedded in tablet.
Initiated
12-31-2021
Reported
01-19-2022
Quantity
3,684 1000-count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Rubicon Research Private Limited
Product was distributed to one distributor who may have distributed the product further nationwide.
Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distributed by: TruPharma, LLC. Tampa, FL 33609; Manufactured by: Rubicon Research Prvate Limited Ambernath, Dist. Thane, 421506 India. NDC 52817-360-00

Batch or Lot Expiration Information

Batch# 210211H1, Exp. date FEB 2024